Published in J Clin Periodontol on December 01, 1996
Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci U S A (2007) 2.39
Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine. Clin Diagn Lab Immunol (1999) 2.08
Current developments in salivary diagnostics. Biomark Med (2010) 1.83
Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am (2005) 1.56
Relationships among gingival crevicular fluid biomarkers, clinical parameters of periodontal disease, and the subgingival microbiota. J Periodontol (2010) 1.29
Matrix metalloproteases: underutilized targets for drug delivery. J Drug Target (2007) 1.21
Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV. Infect Immun (2000) 0.97
MMP3 and TIMP1 variants contribute to chronic periodontitis and may be implicated in disease progression. J Clin Periodontol (2012) 0.89
MMP-9/TIMP-1 imbalance induced in human dendritic cells by Porphyromonas gingivalis. FEMS Immunol Med Microbiol (2010) 0.88
Review of matrix metalloproteinases' effect on the hybrid dentin bond layer stability and chlorhexidine clinical use to prevent bond failure. Open Dent J (2010) 0.87
The Treponema denticola chymotrypsin-like protease dentilisin induces matrix metalloproteinase-2-dependent fibronectin fragmentation in periodontal ligament cells. Infect Immun (2010) 0.87
Peri-implant versus periodontal wound healing. J Clin Periodontol (2013) 0.86
Periodontal treatment reduces matrix metalloproteinase levels in localized aggressive periodontitis. J Periodontol (2013) 0.84
Immunohistochemical analysis of matrix metalloproteinase-13 in human caries dentin. Eur J Histochem (2014) 0.81
Comparison of matrix metalloproteinase-3 and tissue inhibitor of matrix metalloproteinase-1 levels in gingival crevicular fluid in periodontal health, disease and after treatment: A clinico biochemical study. Dent Res J (Isfahan) (2013) 0.80
Estimation of tissue inhibitor of matrix metalloproteinase-1 levels in gingival crevicular fluid in periodontal health, disease and after treatment. J Indian Soc Periodontol (2014) 0.80
Assessment of Matrix Metalloproteinases-8 and -9 in Gingival Crevicular Fluid of Smokers and Non-smokers with Chronic Periodontitis Using ELISA. J Int Oral Health (2015) 0.79
Enamel matrix derivative promotes superoxide production and chemotaxis but reduces matrix metalloproteinase-8 expression by polymorphonuclear leukocytes. J Periodontol (2011) 0.79
Matrix metalloproteinase-8 expression in periodontal tissues surgically removed from diabetic and non-diabetic patients with periodontal disease. J Clin Periodontol (2011) 0.78
Protein biomarkers of periodontitis in saliva. ISRN Inflamm (2014) 0.78
Proteomics - The research frontier in periodontics. J Oral Biol Craniofac Res (2015) 0.78
The effect of adjunctive chlorhexidine mouthrinse on GCF MMP-8 and TIMP-1 levels in gingivitis: a randomized placebo-controlled study. BMC Oral Health (2014) 0.77
Significance of circulating and crevicular matrix metalloproteinase-9 in rheumatoid arthritis-chronic periodontitis association. J Immunol Res (2015) 0.77
Analysis of matrix metalloproteinase-8 levels in gingival crevicular fluid and whole mouth fluid among smokers and nonsmokers using enzyme-linked immune-sorbent assay and a novel chair-side test. J Indian Soc Periodontol (2015) 0.77
Elastase and metalloproteinase-9 concentrations in saliva in patients with chronic periodontitis. Cent Eur J Immunol (2014) 0.76
Influence of phase I periodontal therapy on levels of matrix metalloproteinase 1 and tissue inhibitor of metalloproteinase 1. Saudi Dent J (2014) 0.76
Change of periodontal inflammatory indicators through a 4-week weight control intervention including caloric restriction and exercise training in young Koreans: a pilot study. BMC Oral Health (2015) 0.76
Salivary Markers for Periodontal and General Diseases. Dis Markers (2016) 0.75
Rapid assessment of salivary MMP-8 and periodontal disease using lateral flow immunoassay. Oral Dis (2016) 0.75
Inhibition of endogenous human dentin MMPs by Gluma. Dent Mater (2014) 0.75
Salivary Diagnostics-Point-of-Care diagnostics of MMP-8 in dentistry and medicine. Diagnostics (Basel) (2017) 0.75
Effect of green tea extract on the treatment of dentin erosion: an in vitro study. J Dent (Tehran) (2012) 0.75
Comparison of Salivary TIMP-1 Levels in Periodontally Involved and Healthy Controls and the Response to Nonsurgical Periodontal Therapy. Int J Chronic Dis (2014) 0.75
A meta-analysis of MMP-9 promoter -1562 C/T polymorphism on susceptibility of chronic periodontitis. Springerplus (2016) 0.75
Genomics. Genome project standards in a new era of sequencing. Science (2009) 7.72
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J (1997) 4.07
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res (1998) 3.01
Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature (2000) 2.73
Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci (2001) 2.41
Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol (1999) 2.34
A dedicated cone-beam CT system for musculoskeletal extremities imaging: design, optimization, and initial performance characterization. Med Phys (2011) 2.20
Large-scale concatenation cDNA sequencing. Genome Res (1997) 2.18
Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine. Clin Diagn Lab Immunol (1999) 2.08
Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther (1997) 2.07
Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis (1999) 2.06
Does arthroscopic acromioplasty provide any additional value in the treatment of shoulder impingement syndrome?: a two-year randomised controlled trial. J Bone Joint Surg Br (2009) 2.03
Prevalence and incidence of depressive disorder: the Baltimore ECA follow-up, 1981-2004. Acta Psychiatr Scand (2007) 2.02
The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions. J Dent Res (1998) 2.01
A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem (1998) 1.98
Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest (1998) 1.97
Unusual solution properties of proline and its interaction with proteins. Biochim Biophys Acta (1978) 1.94
Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg (2004) 1.89
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene (2009) 1.85
Regulation of macrophage activation. Cell Mol Life Sci (2003) 1.83
Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem (1997) 1.82
The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J (1994) 1.68
A new member of the acid-sensing ion channel family. Neuroreport (2000) 1.62
Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol Genomics (1999) 1.60
Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum (1997) 1.58
Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord (2002) 1.57
Vitamins A and E, retinol binding protein and zinc in rheumatoid arthritis. Clin Exp Rheumatol (1990) 1.57
Dentists, pills and pregnancies. Br Dent J (1996) 1.54
Effect of topical eutectic mixture of local anesthetics on pain response and analgesic requirement during lithotripsy procedures. Anesth Analg (1994) 1.54
Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc Natl Acad Sci U S A (2000) 1.53
The effect of nisin on murein synthesis. Arch Microbiol (1980) 1.53
Hemodynamics and anatomy of elastase-induced rabbit aneurysm models: similarity to human cerebral aneurysms? AJNR Am J Neuroradiol (2011) 1.51
A 25 kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett (1992) 1.51
Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. J Clin Periodontol (2005) 1.51
MMP-9 as a marker of inflammation in tracheal epithelial lining fluid (TELF) and in bronchoalveolar fluid (BALF) of COPD horses. Equine Vet J (2001) 1.51
Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J (1993) 1.49
A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells. Oncogene (2011) 1.49
A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res (1997) 1.46
Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect Immun (1992) 1.45
Galectin-1 prolongs survival of mouse liver allografts from Flt3L-pretreated donors. Am J Transplant (2013) 1.44
Structural properties of matrix metalloproteinases. Cell Mol Life Sci (1999) 1.43
Factors influencing the diagnosis and management of periodontal disease by general dental practitioners. Br Dent J (1997) 1.43
Cytokine responses of oral epithelial cells to Porphyromonas gingivalis infection. J Dent Res (2000) 1.41
Bone regeneration and stem cells. J Cell Mol Med (2011) 1.41
Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses. Antimicrob Agents Chemother (1996) 1.40
Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res (1998) 1.39
Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia (2008) 1.37
Dental disease, fibrinogen and white cell count; links with myocardial infarction? Scott Med J (1993) 1.36
Task-based modeling and optimization of a cone-beam CT scanner for musculoskeletal imaging. Med Phys (2011) 1.35
Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry (1997) 1.35
Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol (1995) 1.35
A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator. Infect Immun (1989) 1.35
ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. Br Med J (Clin Res Ed) (1982) 1.35
Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg Am (1990) 1.34
HIV risks among gay- and non-gay-identified migrant money boys in Shanghai, China. AIDS Care (2008) 1.33
The expression of angiogenin in tissue samples of different brain tumours and cultured glioma cells. Anticancer Res (2000) 1.32
Fragmentation of human polymorphonuclear-leucocyte collagenase. Biochem J (1993) 1.32
Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic study. FEBS Lett (1994) 1.32
Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum (2000) 1.31
NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Curr Pharm Des (2006) 1.31
Endothelial cell leukocyte adhesion molecule-1 (ELAM-1) and intercellular adhesion molecule-1 (ICAM-1) expression in gingival tissue during health and experimentally-induced gingivitis. J Periodontal Res (1992) 1.31
Candida yeasts in chronic periodontitis tissues and subgingival microbial biofilms in vivo. Oral Dis (2004) 1.31
Spectral encoding of x-ray/optical relative delay. Opt Express (2011) 1.30
Cellular immunohistopathology of acute, subacute, and chronic synovitis in rheumatoid arthritis. Ann Rheum Dis (1985) 1.30
Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol (1988) 1.29
Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol (1996) 1.29
Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum (1986) 1.28
Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav (2013) 1.25
Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J Biol Chem (2000) 1.24
Aggressive granulomatous lesions in cementless total hip arthroplasty. J Bone Joint Surg Br (1990) 1.24
Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob Agents Chemother (1992) 1.23
Impact of smoking on the clinical, microbiological and immunological parameters of adult patients with periodontitis. J Clin Periodontol (2005) 1.22
Comparison of induction, maintenance, and recovery characteristics of sevoflurane-N2O and propofol-sevoflurane-N2O with propofol-isoflurane-N2O anesthesia. Anesth Analg (1992) 1.22
Quadrant root planing versus same-day full-mouth root planing. J Clin Periodontol (2004) 1.21
MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res (2007) 1.21
Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases. Chem Biol (2000) 1.21
Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem (1997) 1.19
Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: a comparative quantitative morphometric study. Br J Rheumatol (1998) 1.19
Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet (1998) 1.19
A trypsin-like protease from Bacteroides gingivalis: partial purification and characterization. J Periodontal Res (1987) 1.19
Insights into MMP-TIMP interactions. Ann N Y Acad Sci (1999) 1.18
Host-pathogen interactions in progressive chronic periodontitis. J Dent Res (2011) 1.18
Latent and active human polymorphonuclear leukocyte collagenases. Isolation, purification and characterisation. Eur J Biochem (1983) 1.18
Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Oral Microbiol Immunol (2008) 1.18
Characterization of the immunocompetent cells of rheumatoid synovium from tissue sections and eluates. Arthritis Rheum (1981) 1.17